Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients-Reference-Cited by-同舟云学术

Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients

Published:1987-11 Issue:5 Volume:76 Page:583-592
ISSN:0001-690X
Container-title:Acta Psychiatrica Scandinavica
language:en
Short-container-title:Acta Psychiatr Scand

Author:

Bouchard J. M.,Delaunay J.,Delisle J.-P.,Grasset N.,Mermberg P. F.,Molczadzki M.,Pagot R.,Richou H.,Robert G.,Ropert R.,Schuller E.,Verdeau-Paillés J.,Zarifian E.,Petersen H. E. Høpfner

Publisher

Wiley

Subject

Psychiatry and Mental health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1987.tb02923.x/fullpdf

Reference17 articles.

1. Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties

2. Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

3. Preliminary studies with citalopram (Lu 10-171), a specific 5-HT-reup-take inhibitor, as antidepressant

4. Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10?171)

5. Citalopram, a selective serotonin reuptake inhibitor: Clinical antidepressive and long-term effect ? a phase II study

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hierarchical and Dynamic Graph Attention Network for Drug-Disease Association Prediction;IEEE Journal of Biomedical and Health Informatics;2024-04

2. Manifold Learning-Based Common Spatial Pattern for EEG Signal Classification;IEEE Journal of Biomedical and Health Informatics;2024-04

3. Toward therapeutic drug monitoring of citalopram in depression? Insights from a systematic review;Frontiers in Psychiatry;2023-04-27

4. Efficacy and safety of Chinese herbal medicine for depression: A systematic review and meta-analysis of randomized controlled trials;Journal of Psychiatric Research;2019-10

5. A quantitative review on outcome-to-antidepressants in melancholic unipolar depression;Psychiatry Research;2018-07